George, D. J., McGowan, T., Daugaard, G., Flaig, T. W., Geczi, L., Hotte, S. J., … Molina, A. (2013). Interim safety results of a global early access protocol (EAP) of abiraterone acetate (AA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) progressing after taxane-based chemotherapy. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 31). Chicago, IL: AMER SOC CLINICAL ONCOLOGY.

George, Daniel J., Tracy McGowan, Gedske Daugaard, Thomas W. Flaig, Lajos Geczi, Sebastien J. Hotte, Paul N. Mainwaring, et al. “Interim safety results of a global early access protocol (EAP) of abiraterone acetate (AA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) progressing after taxane-based chemotherapy.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 31. AMER SOC CLINICAL ONCOLOGY, 2013.

George DJ, McGowan T, Daugaard G, Flaig TW, Geczi L, Hotte SJ, et al. Interim safety results of a global early access protocol (EAP) of abiraterone acetate (AA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) progressing after taxane-based chemotherapy. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2013.

George, Daniel J., et al. “Interim safety results of a global early access protocol (EAP) of abiraterone acetate (AA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) progressing after taxane-based chemotherapy.” JOURNAL OF CLINICAL ONCOLOGY, vol. 31, no. 15, AMER SOC CLINICAL ONCOLOGY, 2013.

George DJ, McGowan T, Daugaard G, Flaig TW, Geczi L, Hotte SJ, Mainwaring PN, Saad F, Smith MR, Souza C, Sternberg CN, Tay MH, Garrido JMT, Londhe A, Naini V, Todd MB, Molina A. Interim safety results of a global early access protocol (EAP) of abiraterone acetate (AA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) progressing after taxane-based chemotherapy. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2013.